LAIZ Regulatory Science Consulting SaRL combine regulatory guidelines and science-based evidence to meet product quality goals at every stage of development.This approach is established in solid understanding of ICH, WHO, EMA & FDA guidelines for biotherapeutic product development.

The company works towards the integration of quality aspects into preclinical and clinical outcomes.

The purpose is to help clients advance in the discovery and commercialization of safe, efficacious, and affordable biologics that will ultimately improve patients quality of life

LAIZ Regulatory Science Consulting SaRL advices, guide and help small and medium size biotech companies to successfully move assets of biological origin from the candidate selection stage to its commercialization. They are specialize in the evaluation of product quality aspects with impact in the safety and efficacy of biologics with a strong focus on translational aspects and immunogenicity.

The goal is to meet regulatory expectations through interpretation of current health authority guidelines applying solid scientific evidence.